美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

奧爾巴尼

21.74

0.0000

成交量：- -

成交額：- -

市值：9.33億

市盈率：-12.08

高：21.74

開：21.74

低：21.74

收：21.74

52周最高：22.17

52周最低：13.01

股本：4,293.20萬

流通股本：1,865.00萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-1.8000

淨資產收益率：--

總資產收益率：--

市淨率：2.94

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

奧爾巴尼

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.amriglobal.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Albany Molecular Research, Inc.於1991年6月20日成立於特拉華州，是一家全球性的合同化研究製造組織。公司為客戶提供全面整合的藥物發明、開發、製造服務。AMRI提供廣泛的服務和技術支持，包括醫藥產品的研發、現有和試驗新藥的原料藥和成品藥的生產。在美國、歐洲、亞洲均有分部，AMRI保持了和客戶在地理上的密切接觸以及靈活多變的成本模式。AMRI也歷史性的利用其藥物開發專業技術施行數個內部藥物開發項目，這些項目已經進入候選研髮狀態，有一些甚至進入了第一期臨床研髮狀態。AMRI已經成功完成一些項目的合作計劃，並正在积極尋求與戰略夥伴就剩餘項目的對外授權事項做進一步發展。公司提供科學的服務、技術以及產品，致力於提高生活質量。公司核心業務為有包括藥物研發、生產的合同服務費用平台。公司還擁有一系列從內部項目產生的專有技術，包括藥物研發、小眾市場產品和製造工藝效率改進，其中一些授權給第三方，有益於公司運作。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AMRI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","market":"US","secType":"STK","nameCN":"奧爾巴尼","latestPrice":21.74,"timestamp":1515186000000,"preClose":21.74,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":18650000,"shares":42932000,"eps":-1.8,"marketStatus":"交易中","change":0,"latestTime":"02-24 10:06:40 EST","open":21.74,"high":21.74,"low":21.74,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.8,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1771966800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":918104400000,"exchange":"NASDAQ","adjPreClose":21.74,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","floatShares":18650000,"roa":"--","roe":"--","lyrEps":0,"shares":42932000,"dividePrice":0,"high":21.74,"amplitude":0,"preClose":21.74,"low":21.74,"week52Low":13.01,"pbRate":"2.94","week52High":22.17,"institutionHeld":0.9503,"latestPrice":21.74,"eps":-1.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.8,"open":21.74,"prevYearClose":21.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-09","symbol":"AMRI","fiscalQuarterEnding":"2017/03","expectedEps":0.07,"name":null,"time":"盤前","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2017-02-21","symbol":"AMRI","fiscalQuarterEnding":"2016/12","expectedEps":0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1487653200000,"reportTimeType":"pre","actualEps":0.3},{"market":"US","date":"2016-11-08","symbol":"AMRI","fiscalQuarterEnding":"2016/09","expectedEps":0.13,"name":null,"time":"盤前","type":"earning","dateTimestamp":1478581200000,"reportTimeType":"pre","actualEps":0.14},{"market":"US","date":"2016-08-04","symbol":"AMRI","fiscalQuarterEnding":"2016/06","expectedEps":0.33,"name":null,"time":"","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"","actualEps":0.32},{"market":"US","date":"2016-05-10","symbol":"AMRI","fiscalQuarterEnding":"2016/03","expectedEps":0.21,"name":null,"time":"盤前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMRI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.amriglobal.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Albany Molecular Research, Inc.於1991年6月20日成立於特拉華州，是一家全球性的合同化研究製造組織。公司為客戶提供全面整合的藥物發明、開發、製造服務。AMRI提供廣泛的服務和技術支持，包括醫藥產品的研發、現有和試驗新藥的原料藥和成品藥的生產。在美國、歐洲、亞洲均有分部，AMRI保持了和客戶在地理上的密切接觸以及靈活多變的成本模式。AMRI也歷史性的利用其藥物開發專業技術施行數個內部藥物開發項目，這些項目已經進入候選研髮狀態，有一些甚至進入了第一期臨床研髮狀態。AMRI已經成功完成一些項目的合作計劃，並正在积極尋求與戰略夥伴就剩餘項目的對外授權事項做進一步發展。公司提供科學的服務、技術以及產品，致力於提高生活質量。公司核心業務為有包括藥物研發、生產的合同服務費用平台。公司還擁有一系列從內部項目產生的專有技術，包括藥物研發、小眾市場產品和製造工藝效率改進，其中一些授權給第三方，有益於公司運作。","exchange":"NASDAQ","name":"奧爾巴尼","nameEN":"Albany Molecular Research"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":null}}